# Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/durvalumab-in-combination-with-olaparib-in-patients-with-relapsed-sclc-results/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Anish Thomas,Rasa Vilimas,Christopher Trindade,Rebecca Erwin-Cohen,Nitin Roper,Liqiang Xi,Venkatesh Krishnasamy,Elliot Levy,Andy Mammen,Samantha Nichols,Yuanbin Chen,Vamsidhar Velcheti,Fang Yin,Éva Szabó,Yves Pommier,Seth M. Steinberg,Jane B. Trepel,Mark Raffeld,Howard A. Young,Javed Khan,Stephen M. Hewitt,Jung-Min Lee |
| Citations | 183 |
| DOI | 10.1016/j.jtho.2019.04.026 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S1556086419303612/pdf |
| OpenAlex ID | https://openalex.org/W2944244934 |
| PMID | 31063862 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Stephen M. Hewitt](https://scholariq.org/researchers/stephen-m-hewitt/)
- [Seth M. Steinberg](https://scholariq.org/researchers/seth-m-steinberg/)
- [Howard A. Young](https://scholariq.org/researchers/howard-a-young/)
- [Yves Pommier](https://scholariq.org/researchers/yves-pommier/)
- [Mark Raffeld](https://scholariq.org/researchers/mark-raffeld/)

## Paper funders

Showing 8 of 13.

- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Novartis](https://scholariq.org/funders/novartis/)
- [Roche](https://scholariq.org/funders/roche/)
- [Gilead Sciences](https://scholariq.org/funders/gilead-sciences/)
- [Celgene](https://scholariq.org/funders/celgene/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.